drugset / Trial / NCT07395232
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase 3, multicenter, randomized, double-masked, parallel-group, vehicle-controlled study to evaluate the safety and efficacy of DFL24498 compared with vehicle ophthalmic solution, in participants with AKC. Approximately 138 participants who meet all eligibility criteria will be enrolled in the study.
Timeline
- Start
- 2025-12-01
- Primary completion
- 2027-03
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DFL24498 | Unknown | — | Other |
| Background | Dexamethasone | Small molecule | — | Other |